Neurocrine Biosciences (NBIX) Cash from Investing Activities (2009 - 2026)
Neurocrine Biosciences' Cash from Investing Activities came in at -$11.1 million for Q3 2026, compared with -$196.7 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Neurocrine Biosciences reported Cash from Investing Activities of -$705.6 million; for FY2025, it was -$264.4 million.
- Going back by year, Cash from Investing Activities was -$126.8 million in FY2024, -$467.1 million in FY2023, -$177.1 million in FY2022 and -$130.2 million in FY2021.
- The Q3 2026 figure represents the highest quarterly Cash from Investing Activities since Q1 2025.
- Business Quant data shows NBIX's Cash from Investing Activities at -$135.4 million (Q2 2026), -$506.2 million (Q1 2026) and -$52.9 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -8.30 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -2.71 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -10.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -1.32 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -649.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -244.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.03 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | -11.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -11.10 Mn |
| Jun 30, 2026 | -135.40 Mn |
| Mar 31, 2026 | -506.20 Mn |
| Dec 31, 2025 | -52.90 Mn |
| Sep 30, 2025 | -196.70 Mn |
| Jun 30, 2025 | -29.00 Mn |
| Mar 31, 2025 | 14.20 Mn |
| Dec 31, 2024 | -68.30 Mn |
| Sep 30, 2024 | 24.70 Mn |
| Jun 30, 2024 | -28.20 Mn |
| Mar 31, 2024 | -55.00 Mn |
| Dec 31, 2023 | -201.80 Mn |
| Sep 30, 2023 | -97.30 Mn |
| Jun 30, 2023 | -125.90 Mn |
| Mar 31, 2023 | -42.10 Mn |
| Dec 31, 2022 | -115.60 Mn |
| Sep 30, 2022 | -61.30 Mn |
| Jun 30, 2022 | 31.40 Mn |
| Mar 31, 2022 | -31.60 Mn |
| Dec 31, 2021 | 23.70 Mn |
API Access
Neurocrine Biosciences Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();